Bach Option’s Bristol-Myers Squibb BMY Stock Holding History

Bach Option’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-10,200	Closed	-$750K	–	162
2016 Q2	$750K	Buy	+10,200	New	+$721K	0.3%	82

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bach Option's BMY Position: Q2 2019 in Review

Bach Option sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 6,450 shares — an estimated $308K sold.

Bach Option first reported a position in BMY in Q3 2016 and held it in 2 quarters. The position peaked at $308K in Q1 2019. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

Bach Option reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
Bach Option sold 6,450 Bristol-Myers Squibb shares in Q2 2019, an estimated $308K.
Bach Option first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 2 quarters.
Bach Option's Bristol-Myers Squibb position peaked at $308K in Q1 2019.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Bach Option's 13F filing for Q2 2019, filed 25 Jul 2019.